These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6597236)

  • 21. Treatment of refractory acute leukemia with high-dose chemotherapy.
    Kramer BS; Appelbaum FR; Herzig GP; Graw RG; Levine AS
    Cancer Treat Rep; 1977 Oct; 61(7):1397-8. PubMed ID: 271045
    [No Abstract]   [Full Text] [Related]  

  • 22. Combination chemotherapy with amsacrine (AMSA) and cyclocytidine in refractory childhood leukemia: preliminary observations of a phase II study.
    Miller LP; Miller DR; Tan CT
    Cancer Treat Rep; 1983 May; 67(5):439-43. PubMed ID: 6189604
    [No Abstract]   [Full Text] [Related]  

  • 23. Cyclocytidine in the treatment of refractory acute childhood leukemia: a Southwest Oncology Group Phase I-II study.
    Miale T; Hvizdala E; Ragab A; Pullen J; O'Brien P; McMillan C
    Cancer Treat Rep; 1979; 63(11-12):1913-5. PubMed ID: 93513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequentially administered 5-azacitidine and amsacrine in refractory adult acute leukemia: a phase I-II trial of the Southeastern Cancer Study Group.
    Winton EF; Hearn EB; Martelo O; Presant CA; Adler S; Vogler WR; Raney M; Logan T; Silberman HM; Omura GA
    Cancer Treat Rep; 1985; 69(7-8):807-11. PubMed ID: 2410119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of acute leukemia in adults. Results with a combination of potent cytotoxic drugs.
    Stavem P; Gjemdal T
    Acta Med Scand; 1974; 196(1-2):121-5. PubMed ID: 4529548
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical use of cytosine arabinoside in childhood. II. Cytosine arabinoside in the prevention and therapy of leukemic meningosis].
    Masi M; Paolucci P; Vivarelli F; Vecchi V
    Minerva Pediatr; 1975 Sep; 27(30):1624-31. PubMed ID: 1058332
    [No Abstract]   [Full Text] [Related]  

  • 27. Leukemia and lymphoma.
    White LP
    Geriatrics; 1970 Dec; 25(12):82-6. PubMed ID: 5274229
    [No Abstract]   [Full Text] [Related]  

  • 28. [Acute leukemia and various hematosarcomas. Trial treatment with a second derivative of podophyllotoxin (4-demethyl-epipodophyllotoxin beta D ethylidene glucoside VP 16213 or EPE)].
    Mathé G; Schwarzenberg L; Pouillart P; Weiner R; Oldham R; Jasmin C; Rosenfeld C; Hayat M; Schneider M; Amiel JL; Céoara B; Steresco-Musset M; de Vassal F
    Nouv Presse Med; 1974 Mar; 3(9):521-4. PubMed ID: 4595555
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of hypoplastic leukemia--clinical effects of low-dose 4N-behenoyl-beta-D-arabinofuranosylcytosine (BH-AC) therapy].
    Nakada H; Takahashi I; Yorimitu S; Hara M; Ohmoto E; Inagaki T; Aoyama S; Nishimura M; Hayashi N; Sekito N
    Rinsho Ketsueki; 1987 Apr; 28(4):534-40. PubMed ID: 3476764
    [No Abstract]   [Full Text] [Related]  

  • 30. [Pharmacokinetic studies of N4-behenoyl-1-beta-D-arabinofuranosylcytosine (BH-AC) by 30-minute infusion with acute nonlymphocytic leukemia--the possibility of administration for outpatients].
    Hirosawa S
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1991-3. PubMed ID: 3164182
    [No Abstract]   [Full Text] [Related]  

  • 31. Cyclocytidine study in the treatment of acute leukemia.
    Yamada K; Kimura K
    Bibl Haematol; 1975; (40):753-4. PubMed ID: 1057949
    [No Abstract]   [Full Text] [Related]  

  • 32. [Quality of survival in patients with acute leukemia subjected to combination drug therapy].
    Almici C; Inzoli MR
    G Clin Med; 1976; 57(5-6):183-91. PubMed ID: 1070454
    [No Abstract]   [Full Text] [Related]  

  • 33. Low dose cytosine arabinoside in adult acute non-lymphoid leukemia.
    Rossi Ferrini P; Ciolli S; Leoni F
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():36-7. PubMed ID: 2713558
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of acute leukemia].
    Barry A; Delage JM
    Union Med Can; 1970 Jun; 99(6):1045-54. PubMed ID: 5280031
    [No Abstract]   [Full Text] [Related]  

  • 35. [New agents in the treatment of leukemia and lymphoma].
    Yamada K
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1031-40. PubMed ID: 6347079
    [No Abstract]   [Full Text] [Related]  

  • 36. [Experiences in the treatment of immature cell leukemias with cytosine arabinoside and daunorubidomycin].
    Schmalzl F; Braunsteiner H
    Wien Klin Wochenschr; 1971 Jun; 83(25):452-6. PubMed ID: 5289111
    [No Abstract]   [Full Text] [Related]  

  • 37. Tallimustine, an effective antileukemic agent in a severe combined immunodeficient mouse model of adult myelogenous leukemia, induces remissions in a phase I study.
    Beran M; Jeha S; O'Brien S; Estey E; Vitek L; Zurlo MG; Rios MB; Keating M; Kantarjian H
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2377-84. PubMed ID: 9815637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. m-AMSA: phase II trial in advanced lymphoma and leukemia.
    Case DC
    Am J Clin Oncol; 1984 Aug; 7(4):357-60. PubMed ID: 6588746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapeutic trials of aclarubicin in previously treated acute leukemias and hematosarcomas].
    Machover D; Goldschmidt E; Benavides M; Gastiaburu J; Vandenbulcke JM; Delgado M; Misset JL; Mathe G
    Pathol Biol (Paris); 1987 Jan; 35(1):79-86. PubMed ID: 3550616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Chemotherapy of acute leukemia].
    Gerhartz H
    Dtsch Med Wochenschr; 1967 Dec; 92(52):2371-5. PubMed ID: 5235193
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.